Smart http://www.cheapambienpriceonline.com Screening
Prostate cancer is the most common, non-skin malignancy diagnosed in men. The statistics regarding the incidence of prostate cancer and the mortality rate are staggering. In 2015 approximately 220,000 men were diagnosed with prostate cancer. It is the second leading cause of cancer death in men, with 27,000 deaths expected in 2015.
African American men have the highest incidence of prostate cancer and the highest mortality rate of any ethnic/racial group. In the Saint Louis Metropolitan Area, the racial disparity related to prostate cancer is greater than any other solid tumor. African American men are 2.3 times more likely to die from prostate cancer than any other racial group. However, if prostate cancer is detected early, the survival rate is excellent regardless of race or ethnicity. If you are an African American male age 45 or older, visit your doctor and ask about prostate cancer screening options. We advocate for Smart Screening and informed decision making. Knowledge is power!
SYMPTOMS and TESTING
Most men with prostate cancer have no symptoms in the early stages of the disease. The most significant advancement in the diagnosis of prostate cancer has been Prostate Specific Antigen (PSA). PSA is an enzyme secreted by both benign and malignant prostate tissue and is evaluated by a simple blood test.PSA provides helpful information about the health of the prostate gland. We advocate having a discussion with your doctor about the potential benefits and drawbacks of this simple blood test. Significant advancements in the diagnosis and treatment of prostate cancer have occurred in the last decade and PSA is just one of many tests that can help guide decision making. When prostate cancer is found early, the survival is greater than 95%. We recommend Smart Screening!
